A new treatment for COVID-19 is in development by Australian company Mesoblast, and has medical experts hopeful. Initial trials of the stem cell treatment in critical coronavirus patients on ventilator support, has a reported 83% survival rate. Subscribe: https://bit.ly/2noaGhv Get more breaking news at: https://bit.ly/2nobVgF

Join Nine News for the latest in news and events that affect you in your local city, as well as news from across Australia and the world.

Follow Nine News on Facebook: https://www.facebook.com/9News/
Follow Nine News on Twitter: https://twitter.com/9NewsAUS
Follow Nine News on Instagram: https://www.instagram.com/9news/

#9News #BreakingNews #NineNewsAustralia #9NewsAUS